This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Baidu, Intermune: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.


Baidu (BIDU - Get Report) rated new Buy at Jefferies. $200 price target. Company is a market leader with limited competition.

Comerica (CMA - Get Report) rated new Market Perform at Morgan Keegan. $38 price target. Visibility remains low for potential loan growth.

Fastenal (FAST - Get Report) upgraded at UBS from Neutral to Buy. $72 price target. Estimates also boosted, as sales growth can drive margin expansion.

Henry Schein (HSIC) upgraded at Goldman to Buy, Goldman Sachs said. $80 price target. Industry should benefit from improving macro trends.

Intermune (ITMN) upgraded to Outperform at Wells Fargo. Expecting a more robust Esbriet launch.

Perrigo (PRGO) upgraded at from Sell to Neutral, Goldman Sachs said. $80 price target. Company can move past the FDA issue and should continue to realize synergies from recent deals.

Riverbed Technology (RVBD) upgraded at ThinkEquity from Hold to Buy. $48 price target. Guidance confirms recent checks that show demand can recover.

Riverbed Technology (RVBD) upgraded at Oppenheimer from Perform to Outperform, Oppenheimer said. $40 price target. Company pre-announced to the upside, easing some demand concerns.

Sirona Dental (SIRO - Get Report) rated new Buy at Goldman. Company was also addded to the Conviction Buy list. Company is leverage to increased spending on high-tech equipment. $61 price target.

Sunoco (SUN - Get Report) downgraded at Benchmark from Hold to Sell, Benchmark Company said. $34 price target. Company is facing an unfavorable settlement for coke pricing.

Dentsply (XRAY - Get Report) rated new Neutral at Goldman Sachs. $39 price target. Stock is already pricing in improving industry growth.

End of report.

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ITMN $73.89 -0.03%
SUN $50.78 0.00%
BIDU $207.87 0.00%
CMA $46.00 0.00%
FAST $40.54 0.00%


DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs